Monday, January 24, 2022


Chinese hackers target SII, Bharat Biotech: Report

Both SII and Bharat Biotech are involved in producing Covid-19 vaccine

Fire at Serum Institute of India an “accident”: Sharad Pawar

Five labourers died in the fire which broke out in a five-storeyed under-construction building in the Serum Institute of India's Manjari premises in Pune.

India dispatches Covishield vaccines to Bangladesh, Nepal

A total of 2 million doses of the Covishield vaccine, by Serum Institute of India, has been dispatched from Mumbai's Chhatrapati Shivaji Maharaj International Airport to Dhaka.

AstraZeneca-Oxford vax not ready for approval: European watchdog

Noel Wathion, number two at the European Medicines Agency, told Belgian newspaper Het Nieuwsblad on Tuesday that the approval for AstraZeneca-Oxford vaccine is still "unthinkable" and Europe

SII seeks emergency use authorisation for its COVID vaccine ‘Covishield’

"SII has applied for emergency use authorisation to DCGI. The application will be reviewed by the expert committee and after that final call will be taken," a senior government official confirmed ANI.

Poonawalla of Serum Institute among 6 named ‘Asians of the Year’ by Singapore daily

Poonawalla joined the Serum Institute of India in 2001 and became the CEO of Serum Institute with complete control of the day-to-day operations of the company in 2011.

Maharashtra CM, Governor not to accompany PM during his SII visit in Pune

Modi began his three-city visit on Saturday to review coronavirus vaccine development work by going to pharma major Zydus Cadila's manufacturing facility near Ahmedabad in the morning.

Serum Institute of India CEO expresses delight at Covishield vaccine efficacy

The Oxford-AstraZeneca vaccine is being made in partnership with Serum Institute.

Serum Institute, ICMR complete enrolment in phase-III trials for COVID-19 vaccine

SII and ICMR are conducting phase II/III clinical trial of the vaccine at 15 different centres across the country.

Latest News

- Advertisement -